Drugs / SEROPLEX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT02042573 | Nov 2013 → Jun 2018 | depressive disorder | Centre Hospitalier Universitaire Dijon | Terminated | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT01962753 Background | May 2012 → Jan 2020 | major depressive disorder | University Hospital, Tours | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Seroplex | “Admnistration of 18FAV45 if patient is compliant with one of those treatment: Seroplex, Zoloft, Deroxat, Venlafaxine, Mirtazapine, Moclamine,” NCT01962753 ↗ |